|
**Overview**: Hypersensitivity Pneumonitis Panel**Introduction**: The Hypersensitivity Pneumonitis Panel is a diagnostic tool designed to screen for hypersensitivity pneumonitis using serum samples. In India, hypersensitivity pneumonitis (HP) is increasingly recognized (~5-15 percent of interstitial lung disease cases), often due to exposure to organic antigens (pigeon/bird droppings, mold, farmer's lung from moldy hay), with high prevalence in rural agricultural and bird-rearing communities. High morbidity from underdiagnosis in rural/low-SES patients with chronic cough, dyspnea, fatigue, limited pulmonology labs, delayed antigen avoidance/corticosteroids leading to irreversible fibrosis or respiratory failure. Per pulmonology practices aligned with ICMR and Indian Chest Society guidelines, the test employs immunoassay for specific IgG antibodies (Aspergillus, pigeon, mold, etc.) over 1-2 days with high specificity, valuable for confirming exposure-related HP in suspected cases. This diagnostic falls under allergic screening and targets patients with ILD features and exposure history (bird fanciers, farmers, moldy environments), addressing accurate detection to guide antigen avoidance and immunosuppression. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise etiological identification and reducing chronic lung disease burden. Its serum-based approach ensures reliable antibody detection.**Other Names**: HP Panel.**FDA Status**: FDA approved, CLIA certified for immunology, compliant with 2025 standards.**Historical Milestone**: Specific IgG panel for HP standard; in India, expanding in ILD clinics.**Purpose**: The test assesses 6 parameters including specific IgG antibodies to guide hypersensitivity pneumonitis screening, detect antigen exposure, inform management.**Test Parameters**: 1â€"6. Specific IgG Antibodies (Aspergillus, Pigeon, etc.).**Pretest Condition**: No fasting required; patients should report dyspnea, cough, exposure history.**Specimen**: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on bird exposure, farming, moldy environments, symptoms.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of undiagnosed HP including fibrosis, benefits of screening, and minimal discomfort from venipuncture.**Procedural Considerations**: The test involves sample processing using immunoassay by trained personnel to ensure sterile technique, avoid hemolysis, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, hemolysis, or low exposure can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Positive specific IgG indicates antigen exposure, necessitating specialist input.**Specialist Consultation**: Pulmonologists should be consulted for management.**Additional Supporting Tests**: HRCT chest, bronchoalveolar lavage for confirmation.**Test Limitations**: Exposure-specific; comprehensive approach required.**References**: Indian Journal of Chest Diseases 2024, ILD Studies India 2023. |
